7 drugmakers in the headlines

The following drug companies made headlines in the past two weeks.

  1. Democratic lawmakers launch investigation into high MS drug prices
    House Democrats are investigating seven drug companies in relation to the high price of multiple sclerosis drugs in the U.S.

  2. Mylan finalizes $465 million settlement with DOJ over EpiPen rebates
    Mylan on Thursday finalized a $465 million settlement with the federal government over accusations the Canonsburg, Pa.-based drugmaker improperly classified EpiPens as a generic drug to overcharge Medicaid.

  1. CDC: Yellow fever vaccine out of stock
    The supply of Sanofi Pasteur's yellow fever vaccine — the only such immunization licensed in the U.S. — is completely depleted and will remain out of stock until mid-2018, according to the CDC. 

  1. Amneal Pharma recalls liquid anxiety drug over dropper defects: 4 things to know
    Amneal Pharmaceuticals on Aug. 14 issued a voluntary recall of its Lorazepam Oral Concentrate solution over issues with the droppers packaged with the medication. 

  1. Nationwide recall issued for all PharmaTech liquid drugs
    Three drug distributors on Aug. 10 issued nationwide recalls for all liquid drugs manufactured by PharmaTech, an Athens, Ga.-based drugmaker.

  1. Stool softeners recalled over bacterial contamination
    Livonia, Mich.-based Rugby Laboratories is recalling its Diocto liquid and Diocto syrup stool softener products over a risk of bacterial contamination. 

  1. Drugmaker raises price of common diarrhea drug by 430%: 4 things to know
    Columbus, Ohio-based West-Ward Pharmaceuticals — the U.S. subsidiary of London-based Hikma Pharmaceuticals — increased the price of a common diarrhea drug by 430 percent.

More articles on supply chain:

7 must-reads for supply chain leaders this week
Mylan finalizes $465 million settlement with DOJ over EpiPen rebates
CDC: Yellow fever vaccine out of stock

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Top 40 Articles from the Past 6 Months